NATURAL BIOMATERIALS MARKET ANALYSIS

Biomaterials have gained tremendous attention in tissue engineering and regenerative medicine applications attributing to their ability to enhance functional tissue regeneration. Biomaterial can be categories into natural biomaterials and synthetic biomaterials. Natural biomaterials offer various advantages over synthetic biomaterials such as they already have binding sites for cells and adhesion molecules so the biocompatibility is not a major issue. On account of advantages offered, the demand for natural biomaterials is projected to upsurge over the forecast period.

Global natural biomaterials market was valued at US$ 75.07 Billion in 2021 in terms of revenue, exhibiting a CAGR of 14.45% during the forecast period (2022 to 2030).

Drivers

Growing substantially over the forecast period, owing to rising prevalence of conditions such as osteoarthritis, rheumatoid arthritis, and sports injuries. Moreover, factors such as rising prevalence of cardiovascular diseases, increasing demand for plastics surgeries, growing cancer incidence are playing major role in fueling growth of the natural biomaterials market.

Naturally derived biomaterials is classified into many groups including polysaccharide-based biomaterials (chitin/chitosan, cellulose, glucose, etc.), protein-based biomaterials (gelatin, collagen, silk, etc.), and de-cellularized tissue-derived biomaterials (blood vessels, liver, heart valves, etc.). Natural biomaterials are preferred over synthetic biomaterials for restoring or replacing structure and for functioning of damaged tissues or organs attributing to their ability to support migration, cell adhesion, differentiation, and proliferation. The three main applications of natural biomaterials in medical are drug delivery system, tissue engineering, and wound management applications.

The COVID-19 pandemic has had a huge impact on the world's population. Rapid development of prophylactic vaccinations and patient treatment methods increased demand for innovative products. Engineered biomaterials were utilized to stimulate certain immune system responses & increase efficacy. Aesthetic operations, including breast augmentation and lipoplasty, and also non-essential dental procedures, have been delayed due to the COVID-19 outbreak. Furthermore, the pandemic had a substantial impact on the U.S., China, Japan, and European countries from March to June of 2020. The bulk of these countries are major biomaterials manufacturers, and the outbreak and global lockdowns have resulted in a drop in sales. This has a negative impact on the biomaterials industry. However, the industry recovered within the next two years as research into the development of a rapid COVID-19 detection test based on gold nanoparticles is expected to drive revenue growth of the market.

Figure 1. Global Natural Biomaterials Market Value Share (%), By Region, 2021

To learn more about this report, Request sample copy

Market Restraints

Lack of reimbursement policies and inadequate supply of natural tissues are estimated to restrain the global natural biomaterials market growth. Difficulties relating to biocompatibility of biomaterials with living tissues are also projected to hamper the market in the near future.

Market Trends

Various development in the gene therapy and medicine industries are considered as one of the major driving factors for the natural biomaterials market in terms of volume and value during the forecasted period.  Advancement in technology and manufacturing process in medical industry with developed equipment in developed and emerging countries are boosting the market growth. Accumulative aged residents have been facing to several chronic diseases is another factor rushing demand in the global natural biomaterials market. Additionally, budding application of biomaterial in numerous advanced medical technologies like plastic surgery, tissue engineering, drug delivery devices, are going to open numerous opportunities for the market growth. On the other hand, use of the targeted material for tissue designing and rising cases of knee and hip replacement surgeries application is further measured as a foremost growth factor.

Figure 2. Global Natural Biomaterials Market Value Share (%), By Application, 2021

To learn more about this report, Request sample copy

Recent Developments

• In June 2022, DuPont, a global leader in innovation through technology-based materials and solutions, completed the previously announced sale of its Biomaterials business unit to the Huafon Group for approximately US$ 240 million.
• In March 2022, Evonik Industries, a stock-listed German specialty chemicals company commercially launched EUDRATEC Fasteric used for enteric fortification and prompt release in the upper smaller intestine, which is a platform of oral drug delivery technology directly over the released target. This product development improved the biocompatibility, safety, and performance of implantable products used by medical device customers and further strengthened Evonik’s growth.

Competitive Section

Major players operating in the global natural biomaterials market include BASF SE, Biomet, Inc., Invibio Ltd., Mimetis Biomaterials, Royal DSM, Corbion N.V., Botiss Biomaterials GmbH, and Medtronic, Inc.